Ali Behbahani

Director; Director, 10% Owner · 11 filings · Latest: Jun 26, 2026

Arcellx, Inc.

Black Diamond Therapeutics, Inc.

CRISPR Therapeutics AG

Korro Bio, Inc.

Monte Rosa Therapeutics, Inc.

Nkarta, Inc.

SpyGlass Pharma, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
SGP	Ali Behbahani	Director, 10% Owner	Feb 9, 2026	Purchase	$16.00	937,500	$15.0M	6,035,038	Feb 11 9:30 PM
CVRX	Behbahani Ali	—	Nov 29, 2024	Proposed Sale	$15.30	21,837	$334.1K	—	Nov 29 7:19 PM
CVRX	Behbahani Ali	—	Nov 18, 2024	Proposed Sale	$14.07	9	$127	—	Nov 18 9:34 PM